The molecular docking of flavonoids isolated from Daucus carota as a dual inhibitor of MDM2 and MDMX

I Muhammad, N Rahman, GE Nayab… - Recent Patents on …, 2020 - ingentaconnect.com
Background: Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …
被引用次数：13 相关文章
[PDF] researchgate.net

[PDF][PDF] The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX

I Muhammad, N Rahman, GE Nayab… - Recent Patents on …, 2020 - researchgate.net
Background: Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …

The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX.

I Muhammad, N Rahman, GE Nayab… - Recent Patents on …, 2020 - europepmc.org
Background Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …

The molecular docking of flavonoids isolated from daucus carota as a dual inhibitor of MDM2 and MDMX

I Muhammad, N Rahman, GE Nayab, S Niaz… - RECENT PATENTS ON …, 2020 - iris.unina.it
Background: Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …

The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX

I Muhammad, N Rahman, GE Nayab… - Recent patents on …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …